Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Influenza
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Adjuvanted quadrivalent flu vacc (SA, inact) inj 0.5ml pfs
1404000H0AAANAN
|
Influenza | Influenza | Immunological Products and Vaccines | 3,090,942 |
|
Influenza vaccine (surface antigen, inact) inj 0.5ml pfs
1404000H0AAAFAF
|
Influenza | Influenza | Immunological Products and Vaccines | 1,371,586 |
|
Adjuvanted trivalent flu vacc (SA, inact) inj 0.5ml pfs
1404000H0AAAMAM
|
Influenza | Influenza | Immunological Products and Vaccines | 613,950 |
|
Quadrivalent Flu/Vac/Split inj 0.5ml pfs
1404000H0BWAAAK
|
Quadrivalent | Influenza | Immunological Products and Vaccines | 573,361 |
|
Flucelvax Tetra vacc inj 0.5ml pre-filled syringes
1404000H0BZAAAF
|
Flucelvax Tetra | Influenza | Immunological Products and Vaccines | 276,794 |
|
Fluad vacc inj 0.5ml pre-filled syringes
1404000H0BXAAAM
|
Fluad | Influenza | Immunological Products and Vaccines | 197,053 |
|
Influvac sub-unit Tetra vacc inj 0.5ml pre-filled syringes
1404000H0BCADAF
|
Influvac Sub-Unit | Influenza | Immunological Products and Vaccines | 172,932 |
|
Quadrivalent Flu/Vac/Split High-Dose inj 0.7ml pfs
1404000H0BWABAQ
|
Quadrivalent | Influenza | Immunological Products and Vaccines | 116,624 |
|
Influvac Sub-unit vacc inj 0.5ml pre-filled syringes
1404000H0BCAAAF
|
Influvac Sub-Unit | Influenza | Immunological Products and Vaccines | 18,483 |
|
Fluad Tetra vaccine inj 0.5ml pre-filled syringes
1404000H0CCAAAN
|
Fluad Tetra | Influenza | Immunological Products and Vaccines | 16,992 |
|
Influenza Tetra MYL vacc inj 0.5ml pre-filled syringes
1404000H0BYAAAF
|
Influenza MYL | Influenza | Immunological Products and Vaccines | 16,473 |
|
Supemtek Quadrivalent vaccine (recombinant) inj 0.5ml pfs
1404000H0CEAAAP
|
Supemtek | Influenza | Immunological Products and Vaccines | 2,423 |
|
Fluarix Tetra vacc inj 0.5ml pre-filled syringes
1404000H0BUAAAK
|
Fluarix Tetra | Influenza | Immunological Products and Vaccines | 2,083 |
|
Trivalent Flu/Vac/SA inj 0.5ml pfs
1404000H0AAARAR
|
Influenza | Influenza | Immunological Products and Vaccines | 1,258 |
|
Imuvac vacc inj 0.5ml pre-filled syringes
1404000H0BNAAAF
|
Imuvac | Influenza | Immunological Products and Vaccines | 818 |
|
Influenza vaccine (split virion, inactivated) inj 0.5ml pfs
1404000H0AAAKAK
|
Influenza | Influenza | Immunological Products and Vaccines | 53 |
|
Fluenz Tetra vaccine nasal suspension 0.2ml unit dose
1404000H0BRABAJ
|
Fluenz | Influenza | Immunological Products and Vaccines | 47 |
|
Trivalent Flu/Vac/Split High Dose inj 0.5ml pfs
1404000H0CBAAAL
|
Trivalent | Influenza | Immunological Products and Vaccines | 23 |
|
Influenza MYL vacc inj 0.5ml pre-filled syringes
1404000H0BYABAF
|
Influenza MYL | Influenza | Immunological Products and Vaccines | 2 |
|
Agrippal vacc inj 0.5ml pre-filled syringes
1404000H0BHAAAF
|
Agrippal | Influenza | Immunological Products and Vaccines | No data available |
|
Begrivac vacc inj 0.5ml pre-filled syringes
1404000H0BGAAAK
|
Begrivac | Influenza | Immunological Products and Vaccines | No data available |
|
Efluelda Trivalent Flu/Vac/Split High Dose inj 0.5ml pfs
1404000H0CHAAAL
|
Efluelda | Influenza | Immunological Products and Vaccines | No data available |
|
Enzira vacc inj 0.5ml pre-filled syringes
1404000H0BLAAAK
|
Enzira | Influenza | Immunological Products and Vaccines | No data available |
|
Flu/Vac/Split 15microg strain inj 0.1ml pfs
1404000H0AAAIAI
|
Influenza | Influenza | Immunological Products and Vaccines | No data available |
|
Flu/Vac/Split 9microg strain inj 0.1ml pfs
1404000H0AAAHAH
|
Influenza | Influenza | Immunological Products and Vaccines | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.